|
|
||||||||



State Key Laboratory of Microbial Technology, Shandong University, Jinan, People's Republic of China 250100
Correspondence
Ping Xu
pingxu{at}sdu.edu.cn
| ABSTRACT |
|---|
|
|
|---|
The GenBank/EMBL/DDBJ accession number for the nucleotide sequence of the 16S rRNA gene of strain S16 determined in this study is AY574282.
These authors contributed equally to this work.
| INTRODUCTION |
|---|
|
|
|---|
Nicotine is also a significant toxic waste product in tobacco production. The tobacco-manufacturing process and all activities that use tobacco produce solid or liquid wastes with high concentrations of nicotine (Novotny & Zhao, 1999
). A non-recyclable, powdery, nicotine-containing waste is formed during tobacco production, which has an average nicotine content of 18 grams per kilogram dry weight. This waste is classified as toxic and hazardous' by European Union regulations when the nicotine content exceeds 500 milligrams per kilogram dry weight (Civilini et al., 1997
). Therefore, there is a major environmental requirement to remove nicotine from tobacco wastes.
Nicotine degradation by micro-organisms has received increasing attention in the past 50 years because micro-organisms have the potential to reduce nicotine levels in tobacco and to detoxify tobacco wastes (Civilini et al., 1997
; Wang et al., 2004
). However, the current understanding of nicotine metabolism in micro-organisms is poor. Some bacteria, such as Pseudomonas sp. no. 41 (Wada & Yamasaki, 1954
), Pseudomonas convexa PC1 (Thacker et al., 1978
), Arthrobacter oxidans (Sguros, 1955
), A. oxidans P-34 (Gherna et al., 1965
; reclassified as Arthrobacter ureafaciens by Kodama et al., 1992
), A. oxidans pAO1 (Decker & Bleeg, 1965
; reclassified as Arthrobacter nicotinovorans by Kodama et al., 1992
) and Achromobacter nicotinophagum (Hylin, 1959
), have been proposed to degrade nicotine, mainly via two different pathways (Kaiser et al., 1996
). In the genus Arthrobacter, the pathway and related metabolic mechanism in the molecular biology of nicotine degradation have been thoroughly elucidated (Gherna et al., 1965
; Brandsch et al., 1982
; Schenk et al., 1998
; Igoli & Brandsch, 2003
). However, the nicotine-degradation mechanisms in Pseudomonas and other genera are less well documented. In Pseudomonas species, pseudoxynicotine, methylamine, 3-succinoylpyridine (SP) and 6-hydroxy-3-succinoylpyridine (HSP) were detected as the initial catabolic products of nicotine by Wada & Yamasaki (1954)
and Tabuchi (1955)
. HSP has been supposed to be further metabolized by cleavage at the 3 position of HSP with the formation of 2,5-dihydroxypyridine (DHP) and succinic acid (Kaiser et al., 1996
). However, until now, no research on the detection or satisfactory characterization of N-methylmyosmine, DHP and succinic acid in nicotine degradation by Pseudomonas species has been reported, and no complete pathway could be reliably constructed. Furthermore, although the identification of the intermediates in earlier investigations was probably correct, the techniques used at the time did not conform to current standards of metabolite characterization.
In our previous publication (Wang et al., 2005
), a green route to HSP from the nicotine of tobacco waste employing whole cells of Pseudomonas sp. S16 was developed, and HSP was easily purified with a 43.8 % (w/w) yield and characterized. However, other metabolites from nicotine have not yet been completely detected and identified. In this paper, we further describe the isolation, identification and characterization of the nicotine-degrading bacterium S16 and the possible intermediates of nicotine degradation. A proposed pathway for nicotine degradation by strain S16 is also postulated and discussed according to the results of NMR, Fourier-transform IR (FT-IR) and UV spectroscopy, GC-MS, and high-resolution MS (HR-MS) analysis, as is the transformation reaction by the cell-free extract.
| METHODS |
|---|
|
|
|---|
99 % purity, purchased as the free base from Fluka) was added to the medium after filter-sterilization. After bacterial growth was observed, the culture was used as an inoculum and transferred twice. The final culture (0.1 ml) was serially diluted and spread onto agar plates containing nicotine. After 2 days, colonies began to appear on plates incubated at 30 °C. The colonies were picked and streaked to purity on nicotine agar plates. One isolate with higher capacity for nicotine degradation was selected for further study. It was routinely and optimally cultured with 3 g nicotine l1 at 30 °C and pH 7.0.
Strain identification and characterization.
Physiological characteristics were determined according to Palleroni (1984)
. Cell morphology was observed using a Hitachi S-570 scanning electron microscope. Fatty acids were analysed using the Sherlock microbial identification system, version 4.0 (MIDI) with the TSBA (revision 4.10) database of the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ). The 16S rRNA gene was amplified by PCR using the oligonucleotides 27f (5'-AGAGTTTGATCMTGGCTCAG-3') and 1492r (5'-TACGGYTACCTTGTTACGACTT-3') as primers (Johnson, 1994
). The fragment generated was purified by agarose gel electrophoresis and band extraction before sequencing analysis. Related sequences were obtained from the GenBank database using the BLASTN search program.
Nicotine degradation by resting cells.
Cells were harvested in mid-exponential phase by centrifugation at 6000 g for 15 min at 4 °C, then washed three times with 0.05 M sodium phosphate buffer (pH 7.0). These cells were called resting cells. The degradation experiment was performed in a 5 l flask containing 3.37 mg dry cell weight (DCW) ml1 of resting cells (OD620
6; 1.0 OD620 unit=0.56 mg DCW ml1), 3 g nicotine l1 and 1 l sterilized 0.05 M sodium phosphate buffer or deionized water (pH adjusted to 7.0 at the beginning of the reaction), at 30 °C with shaking at 120 r.p.m.
General analytical methods.
During the course of bacterial growth or resting cell reaction, aliquots of the culture or cell suspension were sampled and the cells removed by centrifugation at 6000 g for 15 min at 4 °C. The supernatant was used for GC, HPLC, UV absorption and TLC analysis. GC and HPLC analysis was performed as previously described (Wang et al., 2005
). Identification and quantitative data for nicotine, DHP and intermediates were obtained by comparing the retention time and peak areas of the unknown compounds with those of standards (DHP was from SynChem OHG) or of the intermediates of known concentration isolated and purified from this study. The supernatant was also diluted with 0.1 M HCl and scanned with a UV-3100 spectrophotometer (Shimadzu) to record the UV absorption spectra of the metabolites. TLC analysis was carried out as previously described (Wang et al., 2005
), with a slight modification, using silica gel HSGF254 0.20 mm plates (Huanghai) and chloroform/ethanol/methanol/0.5 M NaOH (30 : 15 : 2 : 1.5, v/v) for development. The spots of the metabolites were examined under UV light (254 nm).
Isolation of metabolites SP and HSP.
After incubation of nicotine and resting cells for
3 h, several possible metabolites were found by TLC analysis (Fig. 1b
), and metabolites SP and HSP accumulated. In order to isolate the two metabolites, the reaction was stopped by centrifugation at 12 000 g for 10 min at 4 °C to remove the resting cells. A 1 l volume of supernatant was evaporated at 50 °C under reduced pressure to about 100 ml. To obtain metabolite SP, the condensate was adjusted to pH 4.0 with 1 M HCl, and extracted with chloroform. The chloroform phase was concentrated by evaporation and a white crystalline substance was obtained. To obtain metabolite HSP, the mother liquor after removing metabolite SP was evaporated again to about 50 ml, and 3 M HCl was added until the mixture became cloudy. From this mixture, a brick-red precipitate was obtained by filtration and drying. The two metabolites were purified by recrystallization.
|
Isolation and HR-MS analysis of metabolite A.
In order to obtain metabolite A, the reaction was stopped by centrifugation to remove the resting cells after incubation for
4 h; at that time metabolite A had accumulated to a maximum (Fig. 1b
). The reaction solution was adjusted to pH 11.0 with 1 M NaOH and extracted with chloroform. The chloroform phase was concentrated and applied to preparative TLC on silica gel HSGF254 0.50 mm plates (Huanghai) employing chloroform/ethanol/methanol/0.5 M NaOH (30 : 15 : 2 : 1.5, v/v) for development. The fluorescent spots were detected under a UV light (254 nm). The band of metabolite A on the plate was scraped off and eluted with methanol and ultrasound. After concentration, the eluate was analysed by GC-MS (Waters GCT mass spectrometer, coupled to an Agilent HP6890 gas chromatograph) to record the high-resolution mass spectrum of metabolite A. The system was equipped with a J&W DB-5MS column (0.25 mm internal diameterx50 m lengthx0.25 µm film thickness, Folsom). Chromatographic conditions were: 0.5 µl injection volume (splitless injection, 30 : 1); carrier gas, helium at a constant flow of 1.0 ml min1; temperature programme 50 °C for 2 min, then to 280 °C at a rate of 10 °C min1 for 10 min. The ionization energy was 70 eV, and the temperature was 280 °C with a mass-to-charge ratio of 20600.
GC-MS analysis for other metabolites.
During the nicotine-degradation experiment, the reaction mixture was sampled hourly. After removing the cells, the samples (25 ml) were evaporated to dryness at 50 °C under reduced pressure and dissolved in 2 ml acetonitrile. The acetonitrile solution (0.2 ml) was transferred to a vial and dried under a stream of nitrogen. The residue was silylated by addition of 100 µl bis(trimethylsilyl)trifluoroacetamide (BSTFA; Sigma-Aldrich) at 70 °C for 3 h. After drying under a stream of nitrogen, the sample was redissolved in acetonitrile. Two controls were silylated by the same procedure. One contained nicotine alone without resting cells, and the other contained resting cells without nicotine. The samples were analysed by GC-MS (GCD 1800C, Hewlett Packard) equipped with a 50 m J&W DB-5MS column (Folsom).
Transformation of nicotine and its metabolites by a cell-free extract.
Cells were harvested in mid-exponential phase by centrifugation at 6000 g for 15 min at 4 °C, washed three times with 0.05 M sodium phosphate buffer (pH 7.0), then suspended in the same buffer and disrupted by ultrasonification in an ice/water bath. After centrifugation at 20 000 g for 30 min at 4 °C, the clear supernatant was used as cell-free extract for degradation of nicotine, and the metabolites SP and HSP. All the reactions were performed in a 1 ml total volume at 30 °C with gentle shaking. Reaction mixtures contained 0.05 M sodium phosphate buffer (pH 7.0), an appropriate volume of cell-free extract (a final protein content of 0.3 mg ml1) and substrates at 0.3 mg ml1. The changes in the substrates and the formation of products were determined by UV spectroscopy, GC and HPLC after 30 min (10 min for the HSP degradation reaction).
| RESULTS |
|---|
|
|
|---|
Strain S16 was deposited at the China Center for Type Culture Collection (CCTCC; accession no. M 205038). It was a Gram-negative, mobile, rod-shaped bacterium (0.520.65x1.051.43 µm) with one or two flagella at one pole (data not shown). Its physiological characteristics (data not shown) were identical to those of Pseudomonas putida (Holt et al., 1994
). S16 could grow on glucose, xylose, arabinose, citrate, galactose, rhamnose, glycerol, valine, arginine, alanine, fructose, mannose, creatine and ethanol. However, it could not grow on lactose, sucrose, mannitol, sorbitol, trehalose, raffinose or inositol. Fatty acid analysis of S16 gave a 0.881 similarity index with P. putida biotype A in the TSBA (revision 4.10) database. The partial 16S rRNA gene sequence of S16 (1453 nt; GenBank accession no. AY574282) was determined. BLASTN search analysis revealed that the sequence showed high homology (
99.0 %) with those of P. putida (AB029257.1), Pseudomonas monteilii (AF064458.1), Pseudomonas plecoglossicida (AB009457.1), P. putida KT2440 (AE016774.1) and P. putida ATCC 12633T (AF094736.1). The results suggested that strain S16 was closely related to the genus Pseudomonas. Based on the comparative 16S rRNA gene sequencing, chemotaxonomy, and morphological and physiological data, we concluded that strain S16 belonged to the species P. putida biotype A.
Nicotine degradation by resting cells of S16
To detect the products of nicotine degradation, we carried out the experiments in two different media using resting cells of S16. When the degradation experiment was performed in 0.05 M sodium phosphate buffer (pH 7.0), nicotine was fully degraded in 5 h (Fig. 1a
), while it took more than 8 h to completely decompose nicotine in deionized water (pH adjusted to 7.0 at the beginning of the reaction; see Fig. 1b
). As nicotine was degraded in deionized water, the pH of the suspension dropped, and the low pH value of the mixture inhibited the reaction from proceeding. This suggested that acidic metabolites were formed by the reaction. Moreover, there were substantial changes in both the intensity and the wavelength of the absorption maximum of the UV absorption spectra of the reaction mixture in the degradation experiments (Fig. 1a
). The altered UV absorption suggested the formation of metabolites. Furthermore, several possible metabolites were also found in the TLC analysis (Fig. 1b
).
Isolation and identification of metabolites SP and HSP
Two principal metabolites, SP and HSP, were produced during the incubation reaction (Fig. 1b
), and they were isolated and identified according to the description in Methods. The physical and chemical properties of SP are summarized in Table 1
. The NMR data of HSP have been presented in a previous publication (Wang et al., 2005
). Other properties of HSP determined in this study were: melting point, 290293 °C; UV absorption,
max (in 0.1 M HCl)=276.6 (EM 10246.5), 206.6 (EM 16298.7),
min (in 0.1 M HCl)=230.4;
max (in 0.1 M NaOH)=304.2 (EM 20384.7),
min (in 0.1 M NaOH)=240.8; FTIR (KBr), 3428 and 3240 cm1 (OH), 1719 (CO) cm1. These results confirmed that the metabolites were SP and HSP. The structures of SP and HSP are shown in Fig. 4
(SP is VII and HSP is VIII).
|
|
|
|
7.0), a spot (metabolite B) was found by TLC analysis to show blue fluorescence under 300 nm UV light, and to change to a visibly brown colour after several hours' exposure to air (Fig. 1b
|
For those compounds whose mass spectra could not be well matched in the standard GC-MS library, the structures were identified according to both their molecular ions and their fragment ions (Table 2
, group B, Fig. 4
). They were tentatively suggested to be pseudooxynicotine (IV) and 1-butanone,4-hydroxy-1-(3-pyridinyl) (VI) according to the mass spectra and interpretation of ion fragments. For compound VI, the high-resolution mass spectrum [m/z (relative intensity, %)] [237.1196 (M+, 3.7), 222.0953 (100.0), 204.0822 (7.2), 194.1000 (24.3), 148.0758 (42.1), 130.0647 (9.0), 121.0531 (21.2), 117.0717 (25.7), 116.0656 (34.1), 106.0289 (27.7), 78.0343 (18.4), 75.0265 (43.1), 73.0475 (22.2), 51.0240 (3.6)] was also determined and was identical to the results of analysis by low-resolution GC-MS (Table 2
, group B, VI). The molecular mass determined (237.1196) was in good agreement with that calculated from the molecular formula C12H19NO2Si (237.1185), within 4.6 p.p.m. error. Moreover, the trimethylsilyl (TMS) derivatives of SP and HSP were also detected in the reaction mixture.
Transformation of nicotine and its metabolites by cell-free extract
Nicotine and its metabolites SP and HSP could be transformed into related products by the cell-free extract of S16 (Table 3
). By GC, HPLC and UV analysis, the products of the enzymic reactions could be detected. Nicotine was transformed into N-methylmyosmine (II) and SP. SP and HSP were converted to HSP and DHP, respectively. The results showed that the metabolic sequence of these compounds in the presence of cell-free extract was from nicotine to SP, HSP and DHP via N-methylmyosmine.
|
| DISCUSSION |
|---|
|
|
|---|
In addition, the mechanism of the L-6-hydroxynicotine oxidase in the nicotine degradation pathway of Arthrobacter species (Decker & Dai, 1967
; Dai et al., 1968
) could be helpful to understand the initial attack upon nicotine at the pyrrolidine ring by S16. The flavoprotein converts L-6-hydroxynicotine to 6-hydroxypseudooxynicotine in the presence of oxygen. The overall process consists of the enzyme-catalysed dehydrogenation of L-6-hydroxynicotine to produce 6-hydroxy-N-methylmyosmine and hydrogen peroxide, and the spontaneous hydrolysis of 6-hydroxy-N-methylmyosmine to form 6-hydroxypseudooxynicotine. A similar mechanism has been described for 2,4,6-trichlorophenol 4-monooxygenase in Ralstonia eutropha JMP134, which catalyses the sequential dechlorination of 2,4,6-trichlorophenol to 6-chlorohydroxyquinol by oxidative and hydrolytic reactions (Xun & Webster, 2004
). Hecht et al. (2000)
have reported that nicotine can be metabolized through 2' or 5' hydroxylation by cytochrome P450 2A6 and human liver microsomes by two different pathways: 2'-hydroxynicotine is further decomposed into IV and VII (Fig. 4
), while 5'-hydroxynicotine is converted to cotinine. Because IV and VII were produced in considerable amounts from nicotine degradation by S16 in this study, the highly unstable compound 2'-hydroxynicotine was considered to have a transient existence as the product of hydrolysis in the biochemical reactions that lead to the breaking of the CN bond.
From the known reaction mechanism and general chemical considerations, it can be proposed that the initial attack upon nicotine by S16 is as follows: nicotine (I)
N-methylmyosmine (II)
2'-hydroxynicotine (III)
pseudooxynicotine (IV). Analogically, pseudooxynicotine (IV) could be converted into 3-pyridinebutanal,C-oxo (V) by the same or a similar amine oxidase, while 3-pyridinebutanal,C-oxo (V) could easily be oxidized to 3-succinoyl-pyridine (VII) by aldehyde dehydrogenases. However, we did not find compound V, possibly because it is a transient intermediate in cells.
In nicotinic acid degradation by Pseudomonas fluorescens N-9, hydroxylation at carbon 6 is the first step in the pathway, and this is followed by an oxidative decarboxylation to yield DHP, which is catalysed by nicotinic acid dehydrogenase and 6-hydroxynicotinate 3-monooxygenase (Behrman & Stainier, 1957
; Hurh et al., 1994
; Nakano et al., 1999
). DHP is further degraded by 2,5-dihydryoxypyridine oxygenase into maleamic acid and formic acid (Gauthier & Rittenberg, 1971a
, b
), which are used as nutrients and energy sources to synthesize new cell compounds. In this study, SP and HSP could be transformed by the cell-free system or the resting cells (data not shown) of S16 into HSP and DHP, respectively, so a reaction similar to nicotinic acid metabolism in P. fluorescens is believed to happen in nicotine degradation by S16: SP (VII)
HSP (VIII)
succinic acid (IX)+DHP (X). Furthermore, as shown in Fig. 2
, most of the nicotine (58.9 %, molar conversion) was metabolized into SP, HSP and DHP. However, lactic acid (XI) and 3-hydroxybutyric acid (XII) were detected in this study, and not maleamic acid and formic acid, which might be a result of the rapid reaction caused by the high degradation activity of the cells and an insufficient oxygen supply.
It is interesting that a newly found compound, 1-butanone,4-hydroxy-1-(3-pyridinyl) (VI) was produced during nicotine degradation by the resting cells of S16, and then utilized completely (Fig. 3
). At the same time, lactic acid showed similar behaviour, which indicated that oxygen supply was initially insufficient during nicotine degradation by the resting cells of S16. It can be assumed that a limited oxygen supply makes the degradation reaction slower and leads to accumulation of NAD(P)H and metabolites. However, a high level of NAD(P)H and metabolites is toxic to cells, and it is necessary to convert NAD(P)H and toxic metabolites into NAD(P)+ and non-toxic compounds. In nicotine degradation, the aldehyde compound 3-pyridinebutanal,C-oxo (V), which is usually thought of as a toxic compound, is believed to be transformed into the corresponding alcohol, 1-butanone,4-hydroxy-1-(3-pyridinyl) (VI), accompanied by oxidation of NAD(P)H. Alcohol dehydrogenases, which catalyse the reversible conversion of aromatic and heterocyclic aldehydes to their corresponding alcohols, have been reported in many micro-organisms (Bradshaw et al., 1992a
, b
; Hummel, 1999
; Mee et al., 2005
; Peng et al., 2006
; Tasaki et al., 2006
). When the oxygen supply is adequate, 1-butanone,4-hydroxy-1-(3-pyridinyl) and lactic acid can be oxidized by corresponding dehydrogenases and further decomposed. From another point of view, the formation of the alcohol and the acid SP also verified that the aldehyde compound 3-pyridinebutanal,C-oxo (V) was an important intermediate of nicotine degradation.
Based on our investigations and the known reaction mechanisms, we propose the pathway for nicotine degradation in P. putida S16 shown in Fig. 4
.
The pathways of nicotine metabolism vary in different bacteria. In the Gram-positive Arthrobacter genus, nicotine is hydroxylated at the 6 position before the pyrrolidine ring is opened. The opposite occurs in the Gram-negative Pseudomonas genus, and the further metabolic pathways also differ considerably. 2,3,6-Trihydroxypyridine and DHP are produced, respectively, in these two bacterial genera after the removal of the side chain which is formed by opening the pyrrolidine ring.
In summary, nicotine and some of its metabolites are harmful to health and the environment; this study provides new insights into the nicotine metabolism of micro-organisms and into an environmentally friendly route of nicotine degradation (Wang et al., 2004
, 2005
). It is notable that compound IV is the direct precursor of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) (Hecht, 1999
; Hecht et al., 2000
). The present study suggests that nicotine and its metabolites such as compound IV might be eliminated in later reactions by the Pseudomonas genus when the bacteria are employed to reduce the nicotine content in tobacco and to detoxify tobacco wastes. Moreover, nicotine can be transformed into renewable functionalized pyridines by biocatalytic processes that are difficult to achieve by chemical means (Schmid et al., 2001
). We believe that this is a promising strategy to convert nicotine in tobacco and tobacco wastes into valuable compounds by means of biotechnology. Nicotine could be transformed by P. putida S16 (Fig. 4
) into valuable compounds such as HSP and DHP, which are precursors for the synthesis of drugs and insecticides (Spande et al., 1992
; Roduit et al., 1997
; Nakano et al., 1999
). Preliminary bioconversion processes with S16 have indicated that they are capable of transforming nicotine into HSP with high yields (Wang et al., 2005
). However, the enzymes and genes involved in nicotine degradation by S16 and other Pseudomonas bacteria are still unclear, so future work in our group will focus on the molecular biology of nicotine biodegradation.
| ACKNOWLEDGEMENTS |
|---|
Edited by: D. J. Arp
| REFERENCES |
|---|
|
|
|---|
Behrman, E. J. & Stainier, R. Y. (1957). The bacterial oxidation of nicotinic acid. J Biol Chem 228, 923945.
Benowitz, N. L. & Henningfield, J. E. (1994). Establishing a nicotine threshold for addiction. N Engl J Med 331, 123125.
Bradshaw, C. W., Fu, H., Shen, G. J. & Wong, C.-H. (1992a). A Pseudomonas sp. alcohol dehydrogenase with broad substrate specificity and unusual stereospecificity for organic synthesis. J Org Chem 57, 15261532.[CrossRef]
Bradshaw, C. W., Hummel, W. & Wong, C.-H. (1992b). Lactobacillus kefir alcohol dehydrogenase: a useful catalyst for synthesis. J Org Chem 57, 15321536.[CrossRef]
Brandsch, R., Hinkkanen, A. E. & Decker, K. (1982). Plasmid-mediated nicotine degradation in Arthrobacter oxidans. Arch Microbiol 132, 2630.[CrossRef]
Cai, Z. W., Lee, F. S. C., Wang, X. R. & Yu, W. J. (2002). A capsule review of recent studies on the application of mass spectrometry in the analysis of Chinese medicinal herbs. J Mass Spectrom 37, 10131024.[CrossRef][Medline]
Civilini, M., Domenis, C., Sebastianutto, N. & de Berfoldi, M. (1997). Nicotine decontamination of tobacco agro-industrial waste and its degradation by micro-organisms. Waste Man Res 15, 349358.
Dai, V. D., Decker, K. & Sund, H. (1968). Purification and properties of L-6-hydroxynicotine oxidase. Eur J Biochem 4, 95102.[Medline]
Debrauwer, L. (2000). Use of LC-MS/MS for xenobiotic metabolism studies in animals. Analusis 28, 914920.
Decker, K. & Bleeg, H. (1965). Induction and purification of stereospecific nicotine oxidizing enzymes from Arthrobacter oxidans. Biochim Biophys Acta 105, 313324.[Medline]
Decker, K. & Dai, V. D. (1967). Mechanism and specificity of L- and D-6-hydroxynicotine oxidase. Eur J Biochem 3, 132138.[Medline]
Gauthier, J. J. & Rittenberg, S. C. (1971a). The metabolism of nicotinic acid. I. Purification and properties of 2,5-dihydryoxypyridine oxygenase from Pseudomonas putida N-9. J Biol Chem 246, 37373742.
Gauthier, J. J. & Rittenberg, S. C. (1971b). The metabolism of nicotinic acid. II. 2,5-Dihydryoxypyridine oxidation, product formation, and oxygen 18 incorporation. J Biol Chem 246, 37433748.
Gherna, R. L., Richardson, S. H. & Rittenberg, S. C. (1965). The bacterial oxidation of nicotine. VI. The metabolism of 2,6-dihydroxypseudooxynicotine. J Biol Chem 240, 36693674.
Hecht, S. S. (1999). Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91, 11941210.
Hecht, S. S., Hochalter, J. B., Villalta, P. W. & Murphy, S. E. (2000). 2'-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor. Proc Natl Acad Sci U S A 97, 1249312497.
Henningfield, J. E., Benowitz, N. L., Slade, J., Houston, T. P., Davis, R. M. & Deitchman, S. D. (1998). Reducing the addictiveness of cigarettes. Tob Control 7, 281293.
Holden, C. (2001). Tobacco epidemic in China's future. Science 293, 1761.
Holt, J. G., Krieg, N. R. & Sneath, P. H. A. (1994). Bergey's Manual of Determinative Bacteriology, 9th edn. Baltimore, MD: Williams & Wilkins.
Hummel, W. (1999). Large-scale applications of NAD(P)-dependent oxidoreductases: recent developments. Trends Biotechnol 17, 487492.[CrossRef][Medline]
Hurh, B., Yamane, T. & Nagasawa, T. (1994). Purification and characterization of nicotinic acid dehydrogenase from Pseudomonas fluorescens TN5. J Ferment Bioeng 78, 1926.[CrossRef]
Hylin, J. W. (1959). The microbial degradation of nicotine. II. The mode of action of Achromobacter nicotinophagum. Arch Biochem Biophys 83, 528537.[CrossRef][Medline]
Igoli, G. L. & Brandsch, R. (2003). Sequence of the 165-kilobase catabolic plasmid pAO1 from Arthrobacter nicotinovorans and identification of a pAO1-dependent nicotine uptake system. J Bacteriol 185, 19761986.
Ishikawa, M., Honda, T., Yoshii, H., Ikeda, T. & Iwabuchi, H. (2004). Structure elucidation of novel metabolites of Gemfibrozil in dog: conjugation reaction of conjugated metabolites. J Mass Spectrom Soc Jpn 52, 2128.
Johnson, J. (1994). Similarity analysis of rRNAs. In Methods for General and Molecular Bacteriology, pp. 683670. Edited by P. Gerhardt, R. G. E. Murray, W. A. Wood & N. R. Krieg. Washington, DC: American Society for Microbiology.
Kaiser, J. P., Feng, Y. & Bollag, J. M. (1996). Microbial metabolism of pyridine, quinoline, acridine, and their derivatives under aerobic and anaerobic conditions. Microbiol Rev 60, 483498.
Kodama, Y., Yamamoto, H., Amano, N. & Amachi, T. (1992). Reclassification of two strains of Arthrobacter oxidans and proposal of Arthrobacter nicotinovorans sp. nov. Int J Syst Bacteriol 42, 234239.
Mee, B., Kelleher, D., Frias, J., Malone, R., Tipton, K. F., Henehan, G. T. & Windle, H. J. (2005). Characterization of cinnamyl alcohol dehydrogenase of Helicobacter pylori. An aldehyde dismutating enzyme. FEBS J 272, 12551264.[CrossRef][Medline]
Nakano, H., Wieser, M., Hurh, B., Kawai, T., Yoshida, T., Yamane, T. & Nagasawa, T. (1999). Purification, characterization and gene cloning of 6-hydroxynicotinate 3-monooxygenase from Pseudomonas fluorescens TN5. Eur J Biochem 260, 120126.[Medline]
Novotny, T. E. & Zhao, F. (1999). Consumption and production waste: another externality of tobacco use. Tob Control 8, 7580.
Palleroni, N. J. (1984). Pseudomonas. In Bergey's Manual of Systematic Bacteriology, vol. 1, pp. 141199. Edited by N. R. Krieg & J. G. Holt. Baltimore, MD: Williams & Wilkins.
Peng, X., Taki, H., Komukai, S., Sekine, M., Kanoh, K., Kasai, H., Choi, S. K., Omata, S., Tanikawa, S. & other authors (2006). Characterization of four Rhodococcus alcohol dehydrogenase genes responsible for the oxidation of aromatic alcohols. Appl Microbiol Biotechnol 71, 824832.[CrossRef][Medline]
Roduit, J. P., Wellig, A. & Kiener, A. (1997). Renewable functionalized pyridines derived from microbial metabolites of the alkaloid (S)-nicotine. Heterocycles 45, 16871702.
Schenk, S., Hoelz, A., Krauß, B. & Decker, K. (1998). Gene structures and properties of enzymes of the plasmid-encoded nicotine catabolism of Arthrobacter oxidans. J Mol Biol 284, 13231329.[CrossRef][Medline]
Schmid, A., Dordick, J. S., Hauer, B., Kiener, A., Wubbolts, M. & Witholt, B. (2001). Industrial biocatalysis today and tomorrow. Nature 409, 258268.[CrossRef][Medline]
Sguros, P. L. (1955). Microbial transformations of the tobacco alkaloids. I. Cultural and morphological characteristics of a nicotinophile. J Bacteriol 69, 2837.
Spande, T. F., Garraffo, H. M., Edwards, M. W., Yeh, H. J. C., Pannell, L. & Daly, J. W. (1992). Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadoran poison frog. J Am Chem Soc 114, 34753478.[CrossRef]
Tabuchi, T. (1955). Microbial degradation of nicotine and nicotinic acid. III. Degradation of nicotine. 2. J Agric Chem Soc Jpn 29, 222225.
Tasaki, Y., Yoshikawa, H. & Tamura, H. (2006). Isolation and characterization of an alcohol dehydrogenase gene from the octylphenol polyethoxylate degrader Pseudomonas putida S-5. Biosci Biotechnol Biochem 70, 18551863.[CrossRef][Medline]
Thacker, R., Rørvig, O., Kahlon, P. & Gunsalus, I. C. (1978). NIC, a conjugative nicotine-nicotinate degradative plasmid in Pseudomanas convexa. J Bacteriol 135, 289290.
Wada, E. & Yamasaki, K. (1954). Degradation of nicotine by soil bacteria. J Am Chem Soc 76, 155157.[CrossRef]
Wang, S. N., Xu, P., Tang, H. Z., Meng, J., Liu, X. L., Huang, J., Chen, H., Du, Y. & Blankespoor, H. D. (2004). Biodegradation and detoxification of nicotine in tobacco solid waste by a Pseudomonas sp. Biotechnol Lett 26, 14931496.[CrossRef][Medline]
Wang, S. N., Xu, P., Tang, H. Z., Meng, J., Liu, X. L. & Ma, C. Q. (2005). Green route to 6-hydroxy-3-succinoyl-pyridine from (S)-nicotine of tobacco waste by whole cells of a Pseudomonas sp. Environ Sci Technol 39, 68776880.[Medline]
Xun, L. & Webster, C. M. (2004). A monooxygenase catalyzes sequential dechlorinations of 2,4,6-trichlorophenol by oxidative and hydrolytic reactions. J Biol Chem 279, 66966700.
Received 13 December 2006;
accepted 9 January 2007.
This article has been cited by other articles:
![]() |
H. Tang, L. Wang, X. Meng, L. Ma, S. Wang, X. He, G. Wu, and P. Xu Novel Nicotine Oxidoreductase-Encoding Gene Involved in Nicotine Degradation by Pseudomonas putida Strain S16 Appl. Envir. Microbiol., February 1, 2009; 75(3): 772 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tang, S. Wang, L. Ma, X. Meng, Z. Deng, D. Zhang, C. Ma, and P. Xu A Novel Gene, Encoding 6-Hydroxy-3-Succinoylpyridine Hydroxylase, Involved in Nicotine Degradation by Pseudomonas putida Strain S16 Appl. Envir. Microbiol., March 1, 2008; 74(5): 1567 - 1574. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |